Ad-SGE-REIC is a gene therapy in which the cancer-suppressing gene REIC (Reduced Expression in Immortalized Cells) discovered at Okayama University is incorporated into an adenovirus vector. When the REIC gene is forcibly expressed, cancer cells selectively cause cell death. According to the company, 10 interim analyzes will be carried out in 10 cases during phase II which was started in June.

Nikkei Biotech news release, November 7, 2018